Marshall Wace »

Crispr Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $200k 3.2k 62.60
2023-09-30 $6.2M 136k 45.39
2023-06-30 $26M 457k 56.14
2022-09-30 $712k 11k 65.36
2021-09-30 $29M 256k 111.93
2020-03-31 $81k 1.9k 42.25
2019-12-31 $145k 2.4k 61.08
2018-03-31 $212k 4.6k 45.82